SKYE · Skye Bioscience, Inc.

0001628280-26-023903

Summary

Skye Bioscience, Inc. repriced stock options covering 2,458,158 shares of common stock under Item 5.02 compensatory arrangements.

Key takeaways

Repriced options cover 2,458,158 shares of common stock.
Disclosure made via 8-K/A amendment filed on 2026-04-06.
Pertains to compensatory arrangements for certain officers and directors.

Full analysis

The filing amends prior disclosure under Item 5.02 to specify option repricing, detailing the total shares underlying all repriced options at 2,458,158. This adjustment to compensatory arrangements may signal efforts to retain key personnel amid market conditions affecting option value, potentially impacting dilution and executive incentives for investors.